The IMPACT OF CARDIAC RESYNCHRONISATION THERAPY ON TGF-β 1 SIGNAL PATHWAY IN ISCHAEMIC CARDIOMYOPATHY

Heart - United Kingdom
doi 10.1136/heartjnl-2012-302920a.231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Cardiac Resynchronisation Therapy in New Zealand

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2019English

Current Aspects of Cardiac Resynchronisation Therapy

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2015English

BNIP3L Promotes Cardiac Fibrosis in Cardiac Fibroblasts Through [Ca2+]i-TGF-Β-Smad2/3 Pathway

Scientific Reports
Multidisciplinary
2017English

Current Evidence and Recommendations for Cardiac Resynchronisation Therapy

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2011English

ANO1 Inhibits Cardiac Fibrosis After Myocardial Infraction via TGF-β/smad3 Pathway

Scientific Reports
Multidisciplinary
2017English

Regulation of Ubiquitin Enzymes in the TGF-β Pathway

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Cardiac Resynchronisation Therapy in Chronic Atrial Fibrillation: Impact on Left Atrial Size and Reversal to Sinus Rhythm

Heart
Cardiovascular MedicineCardiology
2005English

Echocardiography and Cardiac Resynchronisation Therapy, Friends or Foes?

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2015English

A Review of Image-Guided Approaches for Cardiac Resynchronisation Therapy

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy